Does TRALOKINUMAB-LDRM Cause Dermatitis exfoliative generalised? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Dermatitis exfoliative generalised have been filed in association with TRALOKINUMAB-LDRM. This represents 0.2% of all adverse event reports for TRALOKINUMAB-LDRM.
8
Reports of Dermatitis exfoliative generalised with TRALOKINUMAB-LDRM
0.2%
of all TRALOKINUMAB-LDRM reports
0
Deaths
0
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From TRALOKINUMAB-LDRM?
Of the 8 reports.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRALOKINUMAB-LDRM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TRALOKINUMAB-LDRM Cause?
Dermatitis atopic (613)
Drug ineffective (461)
Pruritus (365)
Rash (266)
Injection site pain (206)
Injection site erythema (136)
Dry skin (135)
Erythema (133)
Eczema (129)
Injection site pruritus (124)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which TRALOKINUMAB-LDRM Alternatives Have Lower Dermatitis exfoliative generalised Risk?
TRALOKINUMAB-LDRM vs TRAMADOL
TRALOKINUMAB-LDRM vs TRAMADOL\TRAMADOL
TRALOKINUMAB-LDRM vs TRAMETINIB
TRALOKINUMAB-LDRM vs TRAMETINIB DIMETHYL SULFOXIDE
TRALOKINUMAB-LDRM vs TRANDOLAPRIL